Skip to main content

Table 3 Allele frequencies and Hardy–Weinberg estimations of SNPs in the study population

From: Genetic variants of RNASE3 (ECP) and susceptibility to severe malaria in Senegalese population

Polymorphisms RNASE3

MAF (A1 frequency)

HWE*

p value

Allele A1 African (NCBI db)

Allele A1 European (NCBI db)

Location referred to ATG meth start

NCBI dbSNP number

A1

A2

Amino acid change

SM

UM

CTR

Global population

Promoter −550G/A

rs2284954

A

G

0.14

0.11

0.16

0.14

0.07

0.23

0.70

Promoter −399T/C*

rs147413155

C

T

0.08

0.03

0.03

0.04

0.02

0.04

0.00

Promoter −38C/A**

rs2233859

A

C

0.02

0.02

0.05

0.03

0.16

0.03

0.42

Coding +371_G/C

rs2073342

G

C

Arg/Threo

0.46

0.4

0.34

0.41

0.08

0.37

0.71

3′utr +499_G/C

rs2233860

C

G

0.14

0.25

0.23

0.21

0.15

0.23

0.18

3′utr +577_A/T

rs8019343

T

A

0.23

0.19

0.18

0.21

0.83

0.83

0.001

  1. SM Severe malaria, UM Uncomplicated Malaria, CTR Control group HWEp Hardy–Weinberg in global group, p promoter region, c coding region, u untranslated region
  2. * Deviation from Hardy–Weinberg, with values p < 0.012 (corrected threshold)
  3. ** Minor Allele frequency in Global population (MAF) < 0.05